HyperTET S/D and Insulin aspart, recombinant Subcutaneous
Determining the interaction of HyperTET S/D and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: tetanus immune globulin
Brand name: HyperTET S/D
Synonyms: Hypertet S/D
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- HyperTET S/D-Insulin degludec
- HyperTET S/D-Insulin Degludec (U-100) Prefilled Pens
- HyperTET S/D-Insulin Degludec (U-100) Vials
- HyperTET S/D-Insulin Degludec (U-200) Prefilled Pens
- HyperTET S/D-Insulin degludec and liraglutide
- HyperTET S/D-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Hypertonic Dextrose Injection
- Insulin aspart, recombinant Subcutaneous-Hyphed
- Insulin aspart, recombinant Subcutaneous-Hyqvia
- Insulin aspart, recombinant Subcutaneous-Hysingla ER
- Insulin aspart, recombinant Subcutaneous-Hyskon high molecular weight
- Insulin aspart, recombinant Subcutaneous-Hytone